CRT expands drug discovery deal with Merck

30th June 2017 Uncategorised 0

Cancer Research Technology is extending its deal with Germany’s Merck to discover new cancer drugs targeting the Hippo signalling pathway, which regulates cell proliferation and apoptosis to control tissue growth.

More: CRT expands drug discovery deal with Merck
Source: News